Preliminary findings on Timestrip IV
July 01 2009 - 2:00AM
RNS Non-Regulatory
TIDMTIME
Timestrip PLC
01 July 2009
Timestrip plc
("Timestrip" or the "Company")
Preliminary findings by the Whittington Hospital
The Company is pleased to provide an update on the previously announced 'in-use
assessment' of TimestripIV by the Whittington Hospital in London.
TimestripIV is designed to help hospitals comply with existing policy directives
that stipulate the need to change Peripheral Intravenous Cannulae (PVCs) every
72 hours.
The Whittington introduced TimestripIV to a pilot medical ward between 1 May to
13 June 2009 during which time routine inspection of the TimestripIV was
incorporated into the existing Trust wide cannula inspection policy.
The following observations and feedback have now been received:
1. The pilot ward maintained a 100% compliance rate with the Trust's cannula site
inspection policy during the period in question.
2. The Timestrip time elapse display is accurate and correlates well with written
clinical records. It could form the basis of a reliable mechanism of
demonstrating a 'within 72 hour' display without the need to refer to or compile
serial records with a potential saving on nursing time.
3. TimestripIV received positive feedback from some patients who welcomed the
additional information it offered. No adverse patient feedback was received.
4. No adverse comments about TimestripIV were received from the nursing staff
involved in making the cannula site observations and nearly 21% actually
preferred it to the isolated site inspection proforma. Adoption of the
recommendations in point 5 below would be likely to significantly increase this
number by introducing efficiency gains during site inspections.
5. The greatest benefit from Timestrip can be realised by co-locating the Timestrip
and the iv cannula so that visual site inspection of the cannulated site and the
Timestrip display can be looked at in a single observation.
Deborah Wheeler, Director of Nursing & Clinical Development, The Whittington
Hospital: "We are very pleased with the preliminary findings from the pilot. A
focus group of nurses will be conducted shortly to provide feedback on some
basic design changes that have been requested to locate the TimestripIV closer
to the cannulation site, at which time we will explore the option of requesting
that our suppliers include TimestripIV as a standard component in their
Cannulation packs."
For more information please contact:
Paul Freedman, Joint CEO, Timestrip Plc 01462 440700
Geoff Nash, FinnCap, NOMAD 020 7600 1658
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAEAKKEDFSNEFE
Time Finance (LSE:TIME)
Historical Stock Chart
From Jun 2024 to Jul 2024
Time Finance (LSE:TIME)
Historical Stock Chart
From Jul 2023 to Jul 2024